Forbion European Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FRBN research report →
Price Chart
About the company
Forbion European Acquisition Corp. currently has no substantial business activities. Its primary purpose is to complete a strategic corporate transaction, such as a merger, stock exchange, asset acquisition, or restructuring, with other companies.
- CEO
- Jasper M. Bos
- IPO
- 2022
- HQ
- Wilmington, DE, US
Get TickerSpark's AI analysis on FRBN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $47.17
- 52W Low
- $9.25
- 50D MA
- $12.61
- 200D MA
- $11.10
- Beta
- 0.00
- RSI (14)
- 63
- Avg Volume
- 213.44K
No earnings-call transcripts are available for FRBN yet.
- Free Float
- 65.9%
- Shares Outstanding
- 15.81M
- Float Shares
- 10.41M
of shares held by institutions
42 13F filers
Buy/sell ratio 0.67. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Tyrus Capital S.A.M. | 50.00K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 30, 23 | Forbion Growth Sponsor FEAC I B.V. | sell | 666,666 |
| Oct 30, 23 | Forbion Growth Sponsor FEAC I B.V. | sell | 2,000,000 |
| Oct 27, 23 | Forbion Growth Sponsor FEAC I B.V. | other | 1,373,496 |
| Oct 27, 23 | Forbion Growth Sponsor FEAC I B.V. | other | 1,000,000 |
| Oct 27, 23 | Forbion Growth Sponsor FEAC I B.V. | other | 1,373,496 |
| Dec 9, 21 | Forbion Growth Sponsor FEAC I B.V. | other | 0 |
| Dec 9, 21 | Forbion Growth Sponsor FEAC I B.V. | other | 5,195,000 |
| Dec 9, 21 | Forbion Growth Sponsor FEAC I B.V. | other | 3,162,500 |
| Dec 9, 21 | Forbion Growth Sponsor FEAC I B.V. | other | 0 |
| Dec 9, 21 | Forbion Growth Sponsor FEAC I B.V. | other | 3,162,500 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our FRBN coverage
Recent articles, reports, and earnings notes.
No research on FRBN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FRBN report →enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company
prnewswire.com · Nov 1
Why Is Forbion European Acquisition (FRBN) Stock Up 100% Today?
investorplace.com · Oct 27
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.